Study finds bariatric surgery declined with rise in GLP-1 drugs to treat obesity
A new study has examined a large sample of privately insured patients with obesity and found that use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as anti-obesity medications more than doubled from 2022 to 2023.
Are GLP-1 Drugs Putting an End to Bariatric Surgery?
(MedPage Today) —
In this video, Mikhail Varshavski, DO, who goes by “Dr. Mike” on YouTube, talks with Christine J. Ren-Fielding, MD, of NYU Langone Health in New York City, about the future of bariatric surgery.
Following is a partial transcript…
ADA Advises Against Compounded GLP-1s; Growth Hormone Therapy Guide; T1D Outcomes Up
(MedPage Today) — The American Diabetes Association (ADA) urged healthcare providers against prescribing non-FDA approved compounded GLP-1 and dual GIP/GIP-1 receptor agonists for type 2 diabetes or obesity and instead recommended switching to…
STAT+: Pharmalittle: We’re reading about menopause treatments, Novo plans for Wegovy in India, and more
Researchers presented new evidence that hormone therapy can be beneficial to menopausal women’s heart health
Why do Ozempic and Wegovy seem to treat everything?
From Alzheimer’s disease to depression to heart disease, Ozempic and other GLP-1 agonist drugs appear to offer a solution. Can one type of drug really tackle so many conditions, and if so, how does it actually work?
Is Bariatric Surgery at Risk of Becoming Obsolete?
With the advent of GLP-1 analogs, does bariatric surgery have a future role in helping people lose weight? Medscape Medical News
ADA Advises Against Using Compounded GLP-1 RA Medications
In a new guidance statement, the American Diabetes Association advises against the use of unapproved products, warning of safety issues. Medscape Medical News
Curbing plastics pollution could help reduce global burden of breast cancer, analysis suggests
A new study suggests addressing plastic pollution could play a critical role not only in protecting the environment, but also in lowering breast cancer rates, which have been increasing globally, especially in younger adults.
Olema in deal with Novartis on Kisqali breast cancer combo collaboration
Post Content This post firse appeared on Healthcare Articles on Seeking Alpha. Want to know more? Read More
Ozempic and other weight loss drugs could be making people drink less, study says
Another study suggests that weight-loss meds like Wegovy (NVO) and Mounjaro (LLY) can help people cut back on drinking alcohol.Read more…